Artio Medical

About:

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures.

Website: https://artiomedical.com/

Top Investors: National Institutes of Health, Mid-America Angels, Serra Ventures, Accelerate Venture Partners, Kansas Bioscience Authority

Description:

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.

Total Funding Amount:

$73.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Olathe, Kansas, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)artiomedical.com

Founders:

Frank Nicholas Franano, William (Bill) Whitaker

Number of Employees:

1-10

Last Funding Date:

2022-06-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai